Ty T. Kim

789 total citations
10 papers, 658 citations indexed

About

Ty T. Kim is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Ty T. Kim has authored 10 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Physiology. Recurrent topics in Ty T. Kim's work include Sirtuins and Resveratrol in Medicine (4 papers), Cardiovascular Function and Risk Factors (4 papers) and Adipose Tissue and Metabolism (4 papers). Ty T. Kim is often cited by papers focused on Sirtuins and Resveratrol in Medicine (4 papers), Cardiovascular Function and Risk Factors (4 papers) and Adipose Tissue and Metabolism (4 papers). Ty T. Kim collaborates with scholars based in Canada, United States and Austria. Ty T. Kim's co-authors include Jason R.B. Dyck, Miranda M. Sung, Carrie-Lynn M. Soltys, Nikole J. Byrne, Jody Levasseur, Jonathan D. Schertzer, Grant Masson, Karen Madsen, David S. Wishart and Emmanuel Denou and has published in prestigious journals such as Diabetes, American Journal of Physiology-Endocrinology and Metabolism and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Ty T. Kim

10 papers receiving 656 citations

Peers

Ty T. Kim

MB

PHYSI

CCM

GG

EPIDE

Grant Masson Canada

Haitao Xiao China

Aiyun Li China

Dafa Ding China

Francesca Pacifici Italy

Guoyong Zhang China

Heng Miao China

Paramesha Bugga India

Vuyolwethu Mxinwa South Africa

Solveig Hasselwander Germany

Grant Masson Canada

Ty T. Kim

328 ×0.9

MB

179 ×0.7

PHYSI

190 ×1.1

CCM

100 ×0.8

GG

51 ×0.8

EPIDE

Citations per year, relative to Ty T. Kim Ty T. Kim (= 1×) peers Grant Masson

Countries citing papers authored by Ty T. Kim

Since Specialization

Citations

This map shows the geographic impact of Ty T. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ty T. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ty T. Kim more than expected).

Fields of papers citing papers by Ty T. Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ty T. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ty T. Kim. The network helps show where Ty T. Kim may publish in the future.

Co-authorship network of co-authors of Ty T. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Ty T. Kim. A scholar is included among the top collaborators of Ty T. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ty T. Kim. Ty T. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Takahara, Shingo, Shubham Soni, Ty T. Kim, et al.. (2021). Chronic Exogenous Ketone Supplementation Blunts the Decline of Cardiac Function in the Failing Heart. ESC Heart Failure. 8(6). 5606–5612. 36 indexed citations

2.

Kim, Ty T., Nirmal Parajuli, Miranda M. Sung, et al.. (2018). Fecal transplant from resveratrol-fed donors improves glycaemia and cardiovascular features of the metabolic syndrome in mice. American Journal of Physiology-Endocrinology and Metabolism. 315(4). E511–E519. 72 indexed citations

3.

Parajuli, Nirmal, Shingo Takahara, Nobutoshi Matsumura, et al.. (2018). Atglistatin ameliorates functional decline in heart failure via adipocyte-specific inhibition of adipose triglyceride lipase. American Journal of Physiology-Heart and Circulatory Physiology. 315(4). H879–H884. 20 indexed citations

4.

Sung, Miranda M., Nikole J. Byrne, Ian M. Robertson, et al.. (2017). Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 312(4). H842–H853. 68 indexed citations

5.

Sung, Miranda M., Nikole J. Byrne, Ty T. Kim, et al.. (2017). Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 312(3). H552–H560. 41 indexed citations

6.

Kim, Ty T. & Jason R.B. Dyck. (2016). The role of CD36 in the regulation of myocardial lipid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1861(10). 1450–1460. 69 indexed citations

7.

Sung, Miranda M., Ty T. Kim, Emmanuel Denou, et al.. (2016). Improved Glucose Homeostasis in Obese Mice Treated With Resveratrol Is Associated With Alterations in the Gut Microbiome. Diabetes. 66(2). 418–425. 180 indexed citations

8.

Kim, Ty T. & Jason R.B. Dyck. (2014). Is AMPK the savior of the failing heart?. Trends in Endocrinology and Metabolism. 26(1). 40–48. 76 indexed citations

9.

Sung, Miranda M., Subhash K. Das, Jody Levasseur, et al.. (2014). Resveratrol Treatment of Mice With Pressure-Overload–Induced Heart Failure Improves Diastolic Function and Cardiac Energy Metabolism. Circulation Heart Failure. 8(1). 128–137. 81 indexed citations

10.

Nagendran, Jeevan, Petra C. Kienesberger, Thomas Pulinilkunnil, et al.. (2013). Cardiomyocyte specific adipose triglyceride lipase overexpression prevents doxorubicin induced cardiac dysfunction in female mice. Heart. 99(14). 1041–1047. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact